Target Complement system
Aus coViki
Version vom 23. Juni 2020, 10:58 Uhr von Ossip Groth (Diskussion | Beiträge)
32360516 ä. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
32329881 2020. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
32327719 ä. Complement as a target in COVID-19?
| 32271624 2020. Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? |
32495372 2020. Terminal complement inhibition dampens the inflammation during COVID-19.
